Sai Life Sciences Ltd.

₹953.05

-55.8 (-5.5%)

SAILIFE Share Price

Pharmaceuticals & Biotechnology

As on March 13, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 20,017 Cr

P/E Ratio116.75

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	1,000.66	Bearish
10-DMA	1,010.84	Bearish
20-DMA	974.74	Bearish
50-DMA	916.51	Bullish
100-DMA	903.23	Bullish
200-DMA	863.73	Bullish

Historical Performance

1 Year

36.1%

3 Years

N/A

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	16,946	14,652	12,171	8,696	7,599
Total Expenditure	12,867	11,780	10,482	7,447	5,926
Other Income	368	291	280	281	273
Operating Profit	4,446	3,162	1,969	1,530	1,946
Interest	783	876	810	532	331
Depreciation	1,386	1,194	994	902	796
Profit Before Tax	2,277	1,092	164	97	819
Consolidated Net Profit	1,701	828	100	62	611
Adjusted EPS	8	5	---	---	3

Compounded Sales Growth

10 Years:37.9

5 Years:18.5

3 Years:14.3

TTM:3

Compounded Profit Growth

10 Years:48.5

5 Years:17.4

3 Years:93.8

TTM:15.5

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:N/A

TTM:36.1

Return on Equity

10 Years:2.5

5 Years:3.4

3 Years:0.2

last year:8.2

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	208	180	180	179	178
Total Reserves	21,024	9,465	8,606	8,519	8,381
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	3,216	5,936	5,316	5,654	3,557
Other Current Liabilities	2,626	2,188	1,674	1,028	645
Short Term Borrowings	1,286	3,743	3,720	4,041	3,903
Total Liabilities	32,091	23,087	21,786	21,585	18,174
Capital Work in Progress	1,245	1,069	1,510	1,887	2,464
Long Term Loans & Advances	626	738	236	500	634
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	5,348	3,922	4,019	4,210	4,255
Total Current Assets	15,312	9,451	9,640	9,454	8,036
Total Assets	32,091	23,087	21,786	21,585	18,174
Adjusted Book Value	102	55	50	50	48

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 116.75, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 24.6%, indicating sustained price appreciation.
The stock carries a high beta of 1.3, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹4446 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹16946 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1352131.7

No. of Shares: 1419 (Approx)

Performance:35.2%

P/L: ₹352131.7

NIFTY Performance: 3.4%

1 day Top Gainers